Stock Track | Revolution Medicines (RVMD) Surges 5.74% Pre-market on Positive Analyst Sentiment Despite Price Target Cut

Stock Track

May 08, 2025

Revolution Medicines, Inc. (RVMD) saw its stock soar 5.74% in pre-market trading on Thursday, despite mixed signals from Wall Street analysts. The healthcare sector company's shares are gaining momentum following maintained "Buy" ratings from multiple analysts, overshadowing a price target reduction from another firm.

Alec Stranahan, a Wall Street analyst, reiterated a positive stance on Revolution Medicines, citing the company's promising RAS(ON) platform and strong financial position as key factors supporting the bullish outlook. Similarly, Peter Lawson from Barclays maintained a Buy rating on RVMD, reinforcing investor confidence in the company's potential.

However, it's worth noting that Guggenheim cut its price target for Revolution Medicines from $87 to $80. Despite this reduction, the maintained Buy ratings from other analysts appear to be driving the pre-market rally. Investors seem to be focusing on the company's long-term prospects in the healthcare sector, particularly its innovative approaches in drug development, rather than short-term price target adjustments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1190758074"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190758074\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190758074?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-08 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190758074","market":"us","top_or_hot":-1,"title":"Stock Track | Revolution Medicines (RVMD) Surges 5.74% Pre-market on Positive Analyst Sentiment Despite Price Target Cut","media":"Stock Track","content":"<p>Revolution Medicines, Inc. (RVMD) saw its stock soar 5.74% in pre-market trading on Thursday, despite mixed signals from Wall Street analysts. The healthcare sector company's shares are gaining momentum following maintained \"Buy\" ratings from multiple analysts, overshadowing a price target reduction from another firm.</p>\n\n<p>Alec Stranahan, a Wall Street analyst, reiterated a positive stance on Revolution Medicines, citing the company's promising RAS(ON) platform and strong financial position as key factors supporting the bullish outlook. Similarly, Peter Lawson from Barclays maintained a Buy rating on RVMD, reinforcing investor confidence in the company's potential.</p>\n\n<p>However, it's worth noting that Guggenheim cut its price target for Revolution Medicines from $87 to $80. Despite this reduction, the maintained Buy ratings from other analysts appear to be driving the pre-market rally. Investors seem to be focusing on the company's long-term prospects in the healthcare sector, particularly its innovative approaches in drug development, rather than short-term price target adjustments.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Revolution Medicines (RVMD) Surges 5.74% Pre-market on Positive Analyst Sentiment Despite Price Target Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Revolution Medicines (RVMD) Surges 5.74% Pre-market on Positive Analyst Sentiment Despite Price Target Cut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-08 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Revolution Medicines, Inc. (RVMD) saw its stock soar 5.74% in pre-market trading on Thursday, despite mixed signals from Wall Street analysts. The healthcare sector company's shares are gaining momentum following maintained \"Buy\" ratings from multiple analysts, overshadowing a price target reduction from another firm.</p>\n\n<p>Alec Stranahan, a Wall Street analyst, reiterated a positive stance on Revolution Medicines, citing the company's promising RAS(ON) platform and strong financial position as key factors supporting the bullish outlook. Similarly, Peter Lawson from Barclays maintained a Buy rating on RVMD, reinforcing investor confidence in the company's potential.</p>\n\n<p>However, it's worth noting that Guggenheim cut its price target for Revolution Medicines from $87 to $80. Despite this reduction, the maintained Buy ratings from other analysts appear to be driving the pre-market rally. Investors seem to be focusing on the company's long-term prospects in the healthcare sector, particularly its innovative approaches in drug development, rather than short-term price target adjustments.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RVMD","symbol_name":"Revolution Medicines, Inc.","start_time":0,"source_url":"","article_id":"1190758074","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190758074","pubTimestamp":1746705660,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Revolution Medicines, Inc.  saw its stock soar 5.74% in pre-market trading on Thursday, despite mixed signals from Wall Street analysts. The healthcare sector company's shares are gaining momentum following maintained \"Buy\" ratings from multiple analysts, overshadowing a price target reduction from another firm.Alec Stranahan, a Wall Street analyst, reiterated a positive stance on Revolution Medicines, citing the company's promising RAS platform and strong financial position as key factors suppo","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RVMD":"Revolution Medicines, Inc."},"translate_title":"尽管目标价下调，但分析师情绪积极，股票赛道Revolution Medicines(RVMD)盘前飙升5.74%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RVMD":1},"content_text":"Revolution Medicines, Inc. (RVMD) saw its stock soar 5.74% in pre-market trading on Thursday, despite mixed signals from Wall Street analysts. The healthcare sector company's shares are gaining momentum following maintained \"Buy\" ratings from multiple analysts, overshadowing a price target reduction from another firm.\nAlec Stranahan, a Wall Street analyst, reiterated a positive stance on Revolution Medicines, citing the company's promising RAS(ON) platform and strong financial position as key factors supporting the bullish outlook. Similarly, Peter Lawson from Barclays maintained a Buy rating on RVMD, reinforcing investor confidence in the company's potential.\nHowever, it's worth noting that Guggenheim cut its price target for Revolution Medicines from $87 to $80. Despite this reduction, the maintained Buy ratings from other analysts appear to be driving the pre-market rally. Investors seem to be focusing on the company's long-term prospects in the healthcare sector, particularly its innovative approaches in drug development, rather than short-term price target adjustments.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}